Collaborative mechanisms for sustainable health innovation

The provision of key health technologies and products such as vaccines antibiotics is insufficient in purely competitive volume-based markets, requiring new revenue streams for sustainability. Recent developments innovation suggest that innovative collaborative mechanisms can be effective addressing this issue. In the domains antibiotics, these approaches should incorporate shared research investment, long-term access planning, manufacturing infrastructure, supply chains, financial returns. Collaborative subscription models could piloted at regional level, while other developed to delink innovation, manufacturing, from sales volume revenue. Finally, blended finance instruments development field encourage greater collaboration among established emerging stakeholders innovation. These work together create, test, access, implement more share upfront investments, mitigate risks failure, accelerate market access.